Bullish option flow detected in GSK Pharma with 7,657 calls trading, 4x expected, and implied vol increasing over 1 point to 22.73%. Jan-24 41 calls and 1/26 weekly 41 calls are the most active options, with total volume in those strikes near 6,300 contracts. The Put/Call Ratio is 0.17. Earnings are expected on January 31st.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GSK:
- Spyre Therapeutics price target raised to $36 from $27 at Stifel
- Apogee Therapeutics price target raised to $46 from $34 at Stifel
- GSK price target raised to 1,850 GBp from 1,700 GBp at Deutsche Bank
- GSK reports Nucala approved in China for severe eosinophilic asthma
- GSK to acquire Aiolos Bio for $1B upfront